Skip to main content

Table 1 patient characteristics

From: Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients

  clinical event without clinical event  
n = 88 n = 150 p - value
age (in years) 58 ± 10 56 ± 11 n.s.
Male (%) 85 84 n.s.
risk profile    
hypertension (%) 59 52 n.s.
diabetes mellitus 31 11 <0,001
hyperlipidemia (%) 78 78 n.s.
hypercholesterinemia (%) 69 70 n.s.
hypertriglyceridemia (%) 29 32 n.s.
history of smoking or smoking (%) 69 66 n.s.
positive family history (%) 44 42 n.s.
Anamnese    
history of myokardial infarction (%) 44 51 n.s.
history of ACB operation (%) 10 5,4 n.s.
history of PTCA (%) 57 61 n.s.
Medication    
nitrates (%) 87 80 n.s.
calcium channel blockers (%) 50 41 n.s.
betablockers (%) 41 46 n.s.
ace-inhibitors (%) 31 28 n.s.
thrombocytaggregationinhibitors (%) 73 78 n.s.
lipid lowering medication (%) 37 45 n.s.
insuline (%) 1,1 1,4 n.s.
oral andiabetic medication (%) 10 3,4 p < 0,05